Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Citicoline (CDP-choline) is a nootropic compound that enhances cognitive function by increasing phosphatidylcholine synthesis and acetylcholine neurotransmitter levels. Cognizin is a patented, highly bioavailable form of citicoline that supports memory, focus, and brain energy metabolism through ATP elevation.
Reported Benefits (Provisional)
Origin & History
Cognizin is a branded form of Citicoline, a naturally occurring compound in the brain. It is synthesized for use as a dietary supplement to enhance cognitive function.
Research Narrative (Provisional)
Research on Cognizin includes randomized controlled trials (RCTs) showing its potential to improve memory and cognitive function. Meta-analyses have supported its efficacy in cognitive health.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
Cognizin Citicoline (CDP-Choline) is a bioactive compound, not a traditional macronutrient source. It provides no meaningful calories, fat, protein, or dietary fiber. Key compositional breakdown per typical 250–500mg serving: Choline content: approximately 18–21% by molecular weight (yielding ~45–105mg choline per 250–500mg dose), derived from the choline moiety of the CDP-choline molecule. Cytidine content: approximately 26–28% by molecular weight, which is converted to uridine in the body — a nucleoside with its own neuroprotective roles. No significant vitamins or minerals are inherently present in the compound itself. Bioactive compounds: CDP-choline (cytidine 5'-diphosphocholine) is the primary molecule, functioning as an intermediate in phosphatidylcholine biosynthesis via the Kennedy pathway. Upon ingestion, it is hydrolyzed in the gut into free choline and cytidine, both of which cross the blood-brain barrier independently. Choline bioavailability from citicoline is considered high (~100% absorbed orally), superior to choline bitartrate. Uridine (from cytidine conversion) supports UTP and CTP synthesis, contributing to membrane phospholipid production. The Cognizin branded form is produced via fermentation and is standardized to ≥98% citicoline purity. No significant caloric contribution (~0–5 kcal per dose). No fiber, saturated fat, or sugar content.
Reported Mechanism (Provisional)
Citicoline crosses the blood-brain barrier and gets metabolized into cytidine and choline, which then synthesize phosphatidylcholine for neuronal membrane repair. It increases acetylcholine production by providing choline as a precursor and enhances dopamine receptor density in the striatum. The compound also boosts mitochondrial ATP synthesis and cardiolipin levels, improving cellular energy metabolism in neurons.
Clinical Narrative (Provisional)
Multiple randomized controlled trials have demonstrated citicoline's cognitive benefits in healthy adults and those with cognitive decline. Studies show 250-1000mg daily doses improve attention, memory, and psychomotor speed, with one trial reporting 13.6% increased brain energy metabolism. Research includes both healthy populations and patients with stroke, dementia, and traumatic brain injury, though effect sizes are typically modest. Long-term studies spanning 6-12 months support sustained cognitive improvements with minimal side effects.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.